TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31895174

Group type: EXPERIMENTAL
Intervention: Sublingual morphine (10 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Swallowed morphine (10 mg)
Number of subjects: 10
Study: 30999565

Group type: EXPERIMENTAL
Intervention: Raman spectroscopy of blood in microvessels
Number of subjects: 12
Study: 30353267

Group type: EXPERIMENTAL
Intervention: Whole body cryotherapy (WBC) using Cryosense TCT cabin
Number of subjects: 60
Study: 27888177

Group type: EXPERIMENTAL
Intervention: Novartis Access NCD medicines provided through public and private non-profit health facilities.
Number of subjects: 1184

Group type: COMPARATOR
Intervention: Control group (no access to Novartis Access NCD medicines).
Number of subjects: 1184
Study: 25292399

Group type: EXPERIMENTAL
Intervention: Employment-based abstinence reinforcement
Number of subjects: 33
Study: 22344549

Group type: EXPERIMENTAL
Intervention: Test formulation of ondansetron 8 mg orodispersible tablet
Number of subjects: 22

Group type: COMPARATOR
Intervention: Reference formulation of ondansetron 8 mg orodispersible tablet
Number of subjects: 22
Study: 20488402

Group type: EXPERIMENTAL
Intervention: Hydrophilic-coated introducer sheath
Number of subjects: 790

Group type: COMPARATOR
Intervention: Uncoated introducer sheath
Number of subjects: 790

Group type: EXPERIMENTAL
Intervention: Both sheath types
Number of subjects: 790
Study: 17682078

Group type: EXPERIMENTAL
Intervention: One-on-one peer support (treatment group, n = 37)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Usual health care (control group, n = 35)
Number of subjects: 72
Study: 16223581

Group type: EXPERIMENTAL
Intervention: Immediate postoperative irradiation
Number of subjects: 972

Group type: COMPARATOR
Intervention: Wait-and-see (W and S)
Number of subjects: 972
Study: 12137870

Group type: EXPERIMENTAL
Intervention: Collection and analysis of blood, leukocytic DNA, semen, and testicular biopsy
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control group of males with proven fertility
Number of subjects: 132
Study: 10453931

Group type: EXPERIMENTAL
Intervention: 3 g oral ganciclovir daily for 8 weeks
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 6 g oral ganciclovir daily for 8 weeks
Number of subjects: 15
Study: 7605354

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/day
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/day with APOE*2 allele
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/day with APOE*3 allele
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/day with APOE*4 allele
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Meta-analysis including APOE*2 allele
Number of subjects: 625
Study: 2447151

Group type: EXPERIMENTAL
Intervention: citalopram
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: maprotiline
Number of subjects: 29

Group type: COMPARATOR
Intervention: citalopram and maprotiline
Number of subjects: 29

Group type: COMPARATOR
Intervention: Dexamethasone Suppression Test (DST)
Number of subjects: 29

Group type: COMPARATOR
Intervention: HVA and MHPG concentrations in lumbar-CSF
Number of subjects: 29
Study: 29543138

Group type: EXPERIMENTAL
Intervention: Endurance training (T)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Energy-reduced diet (D)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Training and energy increased diet (T-iD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 60
Study: 26752621

Group type: EXPERIMENTAL
Intervention: LY544344 (mGluR2/3 agonist)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 25185277

Group type: EXPERIMENTAL
Intervention: Nasal irrigation (group B)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Nasal steroid spray (group A)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Nasal irrigation combined with nasal steroid (group C)
Number of subjects: 61
Study: 22790213

Group type: EXPERIMENTAL
Intervention: Cimicifuga racemosa extract (CR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20795819

Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (PCV)
Number of subjects: 131

Group type: COMPARATOR
Intervention: 23-valent polysaccharide vaccine (PPV)
Number of subjects: 131
Study: 17928819

Group type: EXPERIMENTAL
Intervention: Individualized dosing of enoxaparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional dosing of enoxaparin
Number of subjects: 0
Study: 19242074

Group type: EXPERIMENTAL
Intervention: Internal sphincterotomy
Number of subjects: 108

Group type: COMPARATOR
Intervention: Topical 2% Diltiazem ointment
Number of subjects: 108
Study: 16356429

Group type: EXPERIMENTAL
Intervention: Overtreatment of thyroid hormone replacement
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Suboptimal initial treatment of thyroid hormone replacement
Number of subjects: 45

Group type: COMPARATOR
Intervention: Initial treatment factors (free thyroxine and TSH concentrations)
Number of subjects: 45
Study: 11977339

Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG) 378 mg/day
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Tiagabine (TGB) 43 mg/g
Number of subjects: 48
Study: 9231868

Group type: EXPERIMENTAL
Intervention: Behavioral treatment for chronic low back pain
Number of subjects: 17

Group type: COMPARATOR
Intervention: Usual medical care (Control)
Number of subjects: 17
Study: 8254858

Group type: EXPERIMENTAL
Intervention: SAPS II score
Number of subjects: 13152
Study: 3301444

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Optimized conventional insulin therapy
Number of subjects: 11
Study: 11571605

Group type: EXPERIMENTAL
Intervention: MCT supplementation during VLCD
Number of subjects: 0

Group type: COMPARATOR
Intervention: LCT supplementation during VLCD
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-fat high-carbohydrate regimen
Number of subjects: 0
Study: 30921815

Group type: EXPERIMENTAL
Intervention: Voluntary blinks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reflexive blinks (elicited by air puffs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temporal displacements (horizontal direction)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Downward displacements (vertical direction)
Number of subjects: 0
Study: 30598705

Group type: EXPERIMENTAL
Intervention: Constant force EMGBFB tibialis anterior exercise
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Variable force EMGBFB tibialis anterior exercise
Number of subjects: 33

Group type: COMPARATOR
Intervention: Upper extremity exercise without EMGBFB (control)
Number of subjects: 33
Study: 27789674

Group type: EXPERIMENTAL
Intervention: Neonatal vitamin A supplementation (50,000 IU)
Number of subjects: 31999

Group type: EXPERIMENTAL
Intervention: Neonatal vitamin A supplementation (50,000 IU) among infants born to women who received a mega-dose of vitamin A postpartum
Number of subjects: 31999

Group type: EXPERIMENTAL
Intervention: Neonatal vitamin A supplementation (50,000 IU) among infants born to women who did not receive a mega-dose of vitamin A postpartum
Number of subjects: 31999
Study: 25394474

Group type: COMPARATOR
Intervention: Tongue scraper
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy applied to the posterior two‐thirds of the dorsum of the tongue
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined treatment (tongue scraper and photodynamic therapy)
Number of subjects: 60
Study: 22814775

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Coronary artery bypass grafts (CABG)
Number of subjects: 334
Study: 20153460

Group type: EXPERIMENTAL
Intervention: Residential Interpersonal Treatment (RIPT)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Residential Cognitive Treatment (RCT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 80
Study: 18179132

Group type: EXPERIMENTAL
Intervention: gemcitabine‐vinorelbine‐cisplatin (GVP) regimen
Number of subjects: 1
Study: 15909190

Group type: EXPERIMENTAL
Intervention: Atosiban
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline infusions (Control)
Number of subjects: 20
Study: 12011543

Group type: EXPERIMENTAL
Intervention: Oral telithromycin 800 mg once daily for 5 days (followed by placebo for 5 days), n = 170
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Oral telithromycin 800 mg once daily for 10 days, n = 171
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Oral telithromycin 800 mg once daily for 5 days
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Oral telithromycin 800 mg once daily for 10 days
Number of subjects: 341
Study: 9614594

Group type: EXPERIMENTAL
Intervention: Doxepin (average daily dose: 169.4 ± 41.6 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Fluoxetine (average daily dose: 36.8 ± 18 mg)
Number of subjects: 36
Study: 8593195

Group type: EXPERIMENTAL
Intervention: Topical formulations (including a new stabilized stannous fluoride dentifrice)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-treated plaque samples
Number of subjects: 0
Study: 2508382

Group type: EXPERIMENTAL
Intervention: Enteral nutrition (2,000 kcal/12.4 g N)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Parenteral nutrition (1,940 kcal/12.4 g N)
Number of subjects: 22
Study: 4549499

Group type: EXPERIMENTAL
Intervention: BCG strain (specific strain not mentioned)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other BCG strains
Number of subjects: 0
Study: 31583813

Group type: EXPERIMENTAL
Intervention: Family constellation seminars (FCS)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 31
Study: 28827229

Group type: EXPERIMENTAL
Intervention: Active tDCS + sensorimotor retraining
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham tDCS + sensorimotor retraining
Number of subjects: 80
Study: 26341847

Group type: EXPERIMENTAL
Intervention: Standard alcohol brief intervention with personalized alcohol response feedback (BI-ARF)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Standard alcohol brief intervention (BI-S)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Health behavior attention control brief intervention (AC)
Number of subjects: 33
Study: 23756854

Group type: EXPERIMENTAL
Intervention: Multisystemic Therapy (MST)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: MST
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Impulsiveness
Number of subjects: 256
Study: 22013492

Group type: EXPERIMENTAL
Intervention: Triple-target treatment (3T)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Low-frequency stimulation (LFS)
Number of subjects: 80
Study: 19643024

Group type: EXPERIMENTAL
Intervention: Neighborhood walking intervention
Number of subjects: 0
Study: 17183987

Group type: EXPERIMENTAL
Intervention: Heparin (unfractionated or low-molecular weight)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ximelagatran
Number of subjects: 0
Study: 12657165

Group type: EXPERIMENTAL
Intervention: 1000 mg acetaminophen, given 6 times daily during 5 days
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 400 mg ibuprofen, given 6 times daily during 5 days
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo, given 6 times daily during 5 days
Number of subjects: 75
Study: 12799920

Group type: EXPERIMENTAL
Intervention: Flupirtine
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Tetrazepam
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 9064108

Group type: EXPERIMENTAL
Intervention: Pamidronate 60 mg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Pamidronate 120 mg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Pamidronate 60 mg and 120 mg
Number of subjects: 26
Study: 1722512

Group type: EXPERIMENTAL
Intervention: Parenteral gold therapy
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Parenteral gold therapy combined with 120 mg intramuscular methylprednisolone acetate at Weeks 0, 4 and 8
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (no treatment mentioned)
Number of subjects: 11
Study: 6357930

Group type: EXPERIMENTAL
Intervention: Diltiazem 60 mg three times daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nifedipine 10 mg four times daily
Number of subjects: 12
Study: 31923736

Group type: EXPERIMENTAL
Intervention: PUQE-24 questionnaire scores at hospital admission
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: NVPQoL questionnaire scores at hospital admission
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Weight change, total days of hospital admission, and readmission
Number of subjects: 215
Study: 30586199

Group type: EXPERIMENTAL
Intervention: BDP/FF DPI
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: BDP/FF pMDI
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 27639387

Group type: EXPERIMENTAL
Intervention: Acotiamide 100 mg × 3/day for 2 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 27107325

Group type: EXPERIMENTAL
Intervention: Mid-luteal phase surgical oophorectomy + oral tamoxifen
Number of subjects: 249

Group type: COMPARATOR
Intervention: Mid-follicular phase surgical oophorectomy + oral tamoxifen
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Luteal phase surgery patients with progesterone levels <2 ng/ml
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Luteal phase surgery patients with progesterone levels ≥2 ng/ml
Number of subjects: 249
Study: 24656301

Group type: COMPARATOR
Intervention: One fluoroscope
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Two fluoroscopes
Number of subjects: 27
Study: 21733056

Group type: EXPERIMENTAL
Intervention: Remogliflozin etabonate 100 mg BID
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Remogliflozin etabonate 1000 mg QD
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Remogliflozin etabonate 1000 mg BID
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 19664258

Group type: EXPERIMENTAL
Intervention: Surgery (surgical reconstruction)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Training only
Number of subjects: 34
Study: 17478452

Group type: EXPERIMENTAL
Intervention: i.v. sufentanil 2.5 microg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: IT sufentanil 2.5 microg
Number of subjects: 90

Group type: COMPARATOR
Intervention: bupivacaine alone
Number of subjects: 90
Study: 15774786

Group type: EXPERIMENTAL
Intervention: 12 weeks of cyclophosphamide, doxorubicin, methotrexate, fluorouracil, and prednisone (CAMFP) before RT (CT-first)
Number of subjects: 244

Group type: COMPARATOR
Intervention: RT-first (radiation therapy before chemotherapy)
Number of subjects: 244
Study: 11753001

Group type: EXPERIMENTAL
Intervention: Red-rubber catheter-guided nasotracheal intubation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nasotracheal tube alone inserted (control group)
Number of subjects: 0
Study: 9549922

Group type: EXPERIMENTAL
Intervention: Magnesium pidolate supplementation at 0.6 mEq/kg/day for four weeks
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Magnesium pidolate supplementation at 1.2 mEq/kg/day for an additional four weeks
Number of subjects: 11

Group type: COMPARATOR
Intervention: Normal controls (17 subjects)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Patients with beta thalassemia intermedia (11 subjects)
Number of subjects: 11
Study: 7932344

Group type: EXPERIMENTAL
Intervention: Esmarch bandages
Number of subjects: 100

Group type: COMPARATOR
Intervention: Simple elevation for 2 min
Number of subjects: 100
Study: 3144330

Group type: EXPERIMENTAL
Intervention: Four layer bandage system
Number of subjects: 126

Group type: COMPARATOR
Intervention: Traditional adhesive plaster bandaging
Number of subjects: 126
Study: 31680023

Group type: EXPERIMENTAL
Intervention: Mindfulness-based therapy (MBT) for PNES, 12 sessions
Number of subjects: 49
Study: 30657649

Group type: EXPERIMENTAL
Intervention: Cold knife
Number of subjects: 22

Group type: COMPARATOR
Intervention: Monopolar cautery
Number of subjects: 22
Study: 28278021

Group type: EXPERIMENTAL
Intervention: Exercise group (N = 12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (N = 12)
Number of subjects: 24
Study: 25829422

Group type: EXPERIMENTAL
Intervention: Interactive iPad program (IP)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Traditional paper format (TF)
Number of subjects: 283
Study: 24104532

Group type: COMPARATOR
Intervention: Spinal anesthesia with 15 mg 0.5% hyperbaric bupivacaine intrathecally
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Iliohypogastric ilioinguinal nerve block (IHNB) with 20 mL 0.5% plain bupivacaine
Number of subjects: 50
Study: 21890825

Group type: EXPERIMENTAL
Intervention: Behavioral sleep intervention (2 to 3 consultations covering behavioral sleep strategies)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Behavioral sleep intervention
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 108
Study: 19220559

Group type: EXPERIMENTAL
Intervention: Training intervention (3-day educational program on depression)
Number of subjects: 1914

Group type: COMPARATOR
Intervention: Control intervention (generic course on disease management in elderly people)
Number of subjects: 1914
Study: 17686670

Group type: EXPERIMENTAL
Intervention: High intensity walking (above 115% of VT or 74% of VO2 max, speeds above 6.14 km/h, mechanical loading of 872.3 N)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Moderate intensity walking (below 115% of VT or 74% of VO2 max)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: High intensity walking
Number of subjects: 43
Study: 15076221

Group type: EXPERIMENTAL
Intervention: Losartan 100 mg daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 11384804

Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg daily for 6 months)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9402540

Group type: EXPERIMENTAL
Intervention: Bacterial meningitis (n = 16)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Aseptic meningitis (n = 12)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control subjects (n = 16)
Number of subjects: 44
Study: 8357888

Group type: EXPERIMENTAL
Intervention: Medication use (including prescription and nonprescription)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Multiple medication use
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Nonprescription medication use
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Knowledge and compliance with medication
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Multiple medication use and wellbeing
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Cognitive functioning
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: General findings
Number of subjects: 178
Study: 3620848

Group type: EXPERIMENTAL
Intervention: Large catheter assembly (4 and 10 F)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Small catheter assembly (epidural line, outside diameter 1.1 mm)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Large catheter assembly (4 and 10 F) before prostatectomy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Small catheter assembly (epidural line, outside diameter 1.1 mm) before prostatectomy
Number of subjects: 30
Study: 2783076

Group type: EXPERIMENTAL
Intervention: 1-year exercise program
Number of subjects: 79

Group type: COMPARATOR
Intervention: Sedentary control condition
Number of subjects: 79
Study: 31801597

Group type: EXPERIMENTAL
Intervention: Oral anticoagulant therapy maintained before surgery
Number of subjects: 96

Group type: COMPARATOR
Intervention: Oral anticoagulant therapy interrupted and substituted with subcutaneous heparin
Number of subjects: 96
Study: 28932091

Group type: EXPERIMENTAL
Intervention: Fixed-time split dose regimen
Number of subjects: 204

Group type: COMPARATOR
Intervention: Split dose regimen
Number of subjects: 204
Study: 26231300

Group type: EXPERIMENTAL
Intervention: Scotchbond Universal total-etch
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Scotchbond Universal self-etch
Number of subjects: 37

Group type: COMPARATOR
Intervention: Scotchbond Multi-purpose
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Scotchbond Universal self-etch and Scotchbond Multi-purpose
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: All adhesive materials
Number of subjects: 37
Study: 23432209

Group type: EXPERIMENTAL
Intervention: Reduced-Intensity Conditioning (RIC)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Myeloablative Conditioning (MAC)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Both RIC and MAC
Number of subjects: 37
Study: 21272401

Group type: EXPERIMENTAL
Intervention: Ground hazelnuts (30 g/d)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Sliced hazelnuts (30 g/d)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Whole hazelnuts (30 g/d)
Number of subjects: 48
Study: 19798037

Group type: EXPERIMENTAL
Intervention: Transcendental Meditation (TM) program
Number of subjects: 298

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 298
Study: 17074626

Group type: EXPERIMENTAL
Intervention: High-Tech-VR helmet (60-degree field-of-view head-mounted display)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Low-Tech-VR helmet (35-degree field-of-view head-mounted display)
Number of subjects: 77
Study: 15636254

Group type: EXPERIMENTAL
Intervention: Topical administration of iodine (3-4 times a day as eye drops)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 360
Study: 11776280

Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9142433

Group type: EXPERIMENTAL
Intervention: Pimobendan 2.5 mg single oral dose
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Pimobendan 5.0 mg single oral dose
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Pimobendan 2.5 mg b.i.d. for 8 weeks
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Pimobendan 1.25 mg and 2.5 mg b.i.d. long-term treatment
Number of subjects: 241

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 241
Study: 10155593

Group type: EXPERIMENTAL
Intervention: lenograstim
Number of subjects: 120
Study: 3297914

Group type: EXPERIMENTAL
Intervention: Micro-K Extencaps
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (ethyl cellulose)
Number of subjects: 0